Oracle today announced the creation of the Oracle Health Sciences Institute (OHSI), in partnership with Sun Labs. The Institute is focused on research that will accelerate IT innovation to advance personalized medicine and the delivery of safe and effective treatments and health care services to patients around the globe.
OHSI will work in tandem with academic research centers, focusing on a targeted set of research areas fundamental to the R&D and health care delivery challenges facing health sciences organizations today. OHSI’s research priorities currently include: artificial intelligence and semantic technology; genomic, genetic and phenotypic data analysis; data mining to support optimization of clinical trials; and predictive algorithms and other technology to advance patient safety and provide advanced decision support at the point of care.
“IT innovation is essential to accelerating the discovery, development and delivery of next-generation treatments, therapies and health care service innovations,” said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences. “Oracle created the Oracle Health Sciences Institute, in partnership with Sun Labs, to advance this objective. By combining Oracle and Sun Labs’ scientific talent and resources with collaborators worldwide, OHSI is positioned to help design IT innovations that will aid in improving patient care around the world.”
Academic institutions interested in collaborating with OHSI in these focus areas should contact OHSI representatives at OHSInstitute_ww@oracle.com for additional information.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.